Search the collection

9 results for Ciruelos,+Eva,+MD

Sort by:

Sort by

Limit results to:

20 per page

9 results for Ciruelos,+Eva,+MD

Export to excel

Export record to excel

File type to download

Beta version

Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 1
ArticlesPeer ReviewedFull Text
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Author / Creator:Swain, Sandra M, Prof ; Miles, David, Prof ; Kim, Sung-Bae, Prof ; Im, Young-Hyuck, Prof ; Im, Seock-Ah, Prof ; Semiglazov, Vladimir, Prof ; Ciruelos, Eva, MD ; Schneeweiss, Andreas, Prof ; Loi, Sherene, Prof ; Monturus, Estefanía, PhD ; Clark, Emma, MSc ; Knott, Adam, PhD ; Restuccia, Eleonora, MD ; Benyunes, Mark C, MD ; Cortés, Javier, Prof
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2020-04, Vol.21 (4), p.519-530
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 2
ArticlesPeer ReviewedFull Text
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
Author / Creator:Swain, Sandra M, Dr ; Kim, Sung-Bae, MD ; Cortés, Javier, MD ; Ro, Jungsil, MD ; Semiglazov, Vladimir, MD ; Campone, Mario, MD ; Ciruelos, Eva, MD ; Ferrero, Jean-Marc, MD ; Schneeweiss, Andreas, MD ; Knott, Adam, PhD ; Clark, Emma, MSc ; Ross, Graham, FFPM ; Benyunes, Mark C, MD ; Baselga, José, MD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2013-05, Vol.14 (6), p.461-471
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 3
ArticlesPeer ReviewedFull Text
Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind,...
Author / Creator:Di Leo, Angelo, MD ; Johnston, Stephen, Prof ; Lee, Keun Seok, MD ; Ciruelos, Eva, MD ; Lønning, Per E, Prof ; Janni, Wolfgang, Prof ; O'Regan, Ruth, Prof ; Mouret-Reynier, Marie-Ange, MD ; Kalev, Dimitar, Prof ; Egle, Daniel, MD ; Csőszi, Tibor, MD ; Bordonaro, Roberto, MD ; Decker, Thomas, MD ; Tjan-Heijnen, Vivianne C G, Prof ; Blau, Sibel, MD ; Schirone, Alessio, MD ; Weber, Denis, MSc ; El-Hashimy, Mona, MD ; Dharan, Bharani, MS ; Sellami, Dalila, MD ; Bachelot, Thomas, MD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2018, Vol.19 (1), p.87-100
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 4
ArticlesPeer ReviewedFull Text
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort
Author / Creator:Gianni, Luca, Dr ; Eiermann, Wolfgang, MD ; Semiglazov, Vladimir, MD ; Lluch, Ana, PhD ; Tjulandin, Sergei, MD ; Zambetti, Milvia, MD ; Moliterni, Angela, MD ; Vazquez, Federico, MD ; Byakhov, Mikhail J, PhD ; Lichinitser, Mikhail, MD ; Climent, Miguel Angel, MD ; Ciruelos, Eva, MD ; Ojeda, Belen, MD ; Mansutti, Mauro, MD ; Bozhok, Alla, PhD ; Magazzù, Domenico, PhD ; Heinzmann, Dominik, PhD ; Steinseifer, Jutta, PhD ; Valagussa, Pinuccia, BS ; Baselga, Jose, MD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2014-05, Vol.15 (6), p.640-647
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 5
ArticlesPeer ReviewedFull Text
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a rand...
Author / Creator:Gianni, Luca, Dr ; Eiermann, Wolfgang, MD ; Semiglazov, Vladimir, MD ; Manikhas, Alexey, MD ; Lluch, Ana, MD ; Tjulandin, Sergey, MD ; Zambetti, Milvia, MD ; Vazquez, Federico, MD ; Byakhow, Mikhail, MD ; Lichinitser, Mikhail, MD ; Climent, Miguel Angel, MD ; Ciruelos, Eva, MD ; Ojeda, Belén, MD ; Mansutti, Mauro, MD ; Bozhok, Alla, MD ; Baronio, Roberta, MSci ; Feyereislova, Andrea, MD ; Barton, Claire, MD ; Valagussa, Pinuccia ; Baselga, Jose, MD
Publisher:Kidlington: Elsevier Ltd
Journal title:The Lancet (British edition), 2010-01, Vol.375 (9712), p.377-384
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 6
ArticlesPeer ReviewedFull Text
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomis...
Author / Creator:Saura, Cristina, MD ; Hlauschek, Dominik, MS ; Oliveira, Mafalda, MD ; Zardavas, Dimitrios, MD ; Jallitsch-Halper, Anita, PhD ; de la Peña, Lorena, PhD ; Nuciforo, Paolo, MD ; Ballestrero, Alberto, MD ; Dubsky, Peter, MD ; Lombard, Janine M, MD ; Vuylsteke, Peter, MD ; Castaneda, Carlos A, MD ; Colleoni, Marco, MD ; Santos Borges, Giuliano, MD ; Ciruelos, Eva, MD ; Fornier, Monica, MD ; Boer, Katalin, MD ; Bardia, Aditya, MD ; Wilson, Timothy R, PhD ; Stout, Thomas J, MD ; Hsu, Jerry Y, MD ; Shi, Yi, PhD ; Piccart, Martine, Prof ; Gnant, Michael, Prof ; Baselga, José, MD ; de Azambuja, Evandro, MD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2019-09, Vol.20 (9), p.1226-1238
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 7
ArticlesPeer ReviewedFull Text
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation
Author / Creator:Prat, Aleix, Prof ; Guarneri, Valentina, MD ; Paré, Laia, PhD ; Griguolo, Gaia, MD ; Pascual, Tomás, MD ; Dieci, Maria V, MD ; Chic, Núria, MD ; González-Farré, Blanca, MD ; Frassoldati, Antonio, MD ; Sanfeliu, Esther, MD ; Cejalvo, Juan M, MD ; Muñoz, Montserrat, MD ; Bisagni, Giancarlo, MD ; Brasó-Maristany, Fara, PhD ; Urso, Loredana, MD ; Vidal, Maria, MD ; Brandes, Alba A, MD ; Adamo, Barbara, MD ; Musolino, Antonino, MD ; Miglietta, Federica, MD ; Conte, Benedetta, MD ; Oliveira, Mafalda, MD ; Saura, Cristina, MD ; Pernas, Sònia, MD ; Alarcón, Jesús, MD ; Llombart-Cussac, Antonio, MD ; Cortés, Javier, MD ; Manso, Luis, MD ; López, Rafael, MD ; Ciruelos, Eva, MD ; Schettini, Francesco, MD ; Villagrasa, Patricia, PhD ; Carey, Lisa A, MD ; Perou, Charles M, PhD ; Piacentini, Federico, MD ; D'Amico, Roberto, MD ; Tagliafico, Enrico, MD ; Parker, Joel S, PhD ; Conte, Pierfranco, Prof
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2020-11, Vol.21 (11), p.1455-1464
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 8
ArticlesPeer ReviewedFull Text
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizum...
Author / Creator:von Minckwitz, Gunter, Prof ; Puglisi, Fabio, MD ; Cortes, Javier, MD ; Vrdoljak, Eduard, Prof ; Marschner, Norbert, MD ; Zielinski, Christoph, Prof ; Villanueva, Cristian, MD ; Romieu, Gilles, MD ; Lang, István, Prof ; Ciruelos, Eva, MD ; De Laurentiis, Michele, MD ; Veyret, Corinne, Prof ; de Ducla, Sabine, DEA ; Freudensprung, Ulrich, MSc ; Srock, Stefanie, MD ; Gligorov, Joseph, MD
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2014-10, Vol.15 (11), p.1269-1278
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.
Export this record
Export to excel
Print
Export record to excel
File type to download
Beta version
Select record 9
ArticlesPeer ReviewedFull Text
Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breas...
Author / Creator:Cortés, Javier, Dr ; Dieras, Véronique, MD ; Ro, Jungsil, MD ; Barriere, Jérôme, MD ; Bachelot, Thomas, MD ; Hurvitz, Sara, MD ; Le Rhun, Emilie, MD ; Espié, Marc, MD ; Kim, Sung-Bae, MD ; Schneeweiss, Andreas, MD ; Sohn, Joo Hyuk, MD ; Nabholtz, Jean-Marc, Prof ; Kellokumpu-Lehtinen, Pirkko-Liisa, Prof ; Taguchi, Julie, MD ; Piacentini, Federico, MD ; Ciruelos, Eva, MD ; Bono, Petri, MD ; Ould-Kaci, Mahmoud, MD ; Roux, Flavien, MSc ; Joensuu, Heikki, Prof
Publisher:England: Elsevier Ltd
Journal title:The lancet oncology, 2015-12, Vol.16 (16), p.1700-1710
View online as a Library member
Access ebook if you are in the Library. Registered NSW residents may log in from home.

Export record to excel

Export this record

Export record to excel

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Export this record

Export record to excel

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study

Export this record

Export record to excel

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind,...

Export this record

Export record to excel

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

Export this record

Export record to excel

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a rand...

Export this record

Export record to excel

Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomis...

Export this record

Export record to excel

A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation

Export this record

Export record to excel

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizum...

Export this record

Export record to excel

Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breas...

Refine your search